Apertura Gene Therapy Funding: $67M Raised, Series A (2022)
Apertura Gene Therapy is based in New York, NY. It has raised $67M in total funding. Latest round: Series A. Backed by Deerfield Management Company.
Apertura Gene Therapy funding overview
Apertura Gene Therapy is based in New York, NY. Apertura Gene Therapy has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for Apertura Gene Therapy runs through 2022; nothing later has been disclosed. Investors on record include Deerfield Management Company.
Apertura Gene Therapy at a glance
Total raised
$67M
Latest round
Series A
Latest round date
April 2022
Headquarters
New York, NY
Notable investors
Deerfield Management Company
Frequently asked about Apertura Gene Therapy funding
How much has Apertura Gene Therapy raised?
Apertura Gene Therapy has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Apertura Gene Therapy?
Deerfield Management Company are named among the investors backing Apertura Gene Therapy.
What was the latest Apertura Gene Therapy funding round?
The most recent disclosed round is a Series A, announced in April 2022.
Where is Apertura Gene Therapy based?
Apertura Gene Therapy is based in New York, NY.
When did Apertura Gene Therapy last raise?
The last disclosed Apertura Gene Therapy round closed in April 2022 at Series A.
Every Apertura Gene Therapy figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.
